UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

711 Outcomes of diverse recruitment strategies in the Home-Reported Outcomes with CFTR Modulator Therapy study

Journal of cystic fibrosis, 2024-09, Vol.23, p.S401-S402

2024

Volltextzugriff (PDF)

319 I1023_V1024del-CFTR theratyping using patient-derived nasal epithelial cells

Journal of cystic fibrosis, 2023-10, Vol.22, p.S160-S160

2023

Volltextzugriff (PDF)

671 Home reported outcomes in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor: feasibility of conducting a real-world protocol

Journal of cystic fibrosis, 2023-10, Vol.22, p.S367-S368

2023

Volltextzugriff (PDF)

P092 Preliminary observations of treatment and symptom reporting in the Home-Reported Outcomes in cystic fibrosis study (HERO-2)

Journal of cystic fibrosis, 2023-06, Vol.22, p.S92-S92

2023

Volltextzugriff (PDF)

P113 Home reported outcomes (HERO-2) in people with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor: self-reported changes in use of chronic daily therapies at enrollment

Journal of cystic fibrosis, 2023-06, Vol.22, p.S98-S98

2023

Volltextzugriff (PDF)

140 Home Reported Outcomes Study (HERO-2): end-of-study participant-reported physical and mental health changes

Journal of cystic fibrosis, 2024-09, Vol.23, p.S77-S78

2024

Volltextzugriff (PDF)

709 Longitudinal Cystic Fibrosis Respiratory Symptom Diary—Chronic Respiratory Infection Symptom Score Questionnaire and PROMIS10 scores from the Home Reported Outcomes Study in people with CF taking elexacaftor/tezacaftor/ivacaftor

Journal of cystic fibrosis, 2024-09, Vol.23, p.S399-S400

2024

Volltextzugriff (PDF)

141 Lung function and pulmonary exacerbations in individuals who discontinue chronic daily respiratory therapies: results of the Home Reported Outcomes Study-2 (HERO-2)

Journal of cystic fibrosis, 2024-09, Vol.23, p.S78-S78

2024

Volltextzugriff (PDF)

P105 Patient reported outcomes in people with CF taking elexacaftor/tezacaftor/ivacaftor (ETI) in the Home-Reported Outcomes (HERO-2) study

Journal of cystic fibrosis, 2024-06, Vol.23, p.S117-S117

2024

Volltextzugriff (PDF)

610 Clinical features associated with changes in chronic daily therapies in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor: Results from the Home Reported Outcomes 2 Study

Journal of cystic fibrosis, 2023-10, Vol.22, p.S325-S325

2023

Volltextzugriff (PDF)

115 Baseline symptom tracking in the Home Reported Outcome Study (HERO-2) in people with cystic fibrosis taking elexacaftor-tezacaftorivacaftor

Journal of cystic fibrosis, 2023-10, Vol.22, p.S61-S61

2023

Volltextzugriff (PDF)

Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life

JAMA pediatrics, 2017-06, Vol.171 (6), p.546

2017

Volltextzugriff (PDF)

A27 ADVANCES IN PEDIATRIC SLEEP: The Effect Of Continuous Positive Airway Pressure (cpap) Therapy On Obese Children With Stable Asthma

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

American journal of respiratory and critical care medicine, 2011-03, Vol.183 (5), p.627-634

2011

Volltextzugriff (PDF)

A104 ASTHMA EPIDEMIOLOGY: Association Between Sugar Cane Burning And The Prevalence Of Asthma, Atopy And Pulmonary Function Changes In Rural Honduran Children

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis

CHEST pulmonary, 2024-06, p.100080, Article 100080

2024

Volltextzugriff (PDF)

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients

Pediatric pulmonology, 2015-08, Vol.50 (8), p.763-770

2015

Volltextzugriff (PDF)

Effectiveness of forestry best management practices (BMPs) for reducing the risk of forest herbicide use to aquatic organisms in streams

Forest ecology and management, 2017-11, Vol.404, p.258-268

2017

Volltextzugriff (PDF)

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

Journal of cystic fibrosis, 2012-09, Vol.11 (5), p.446-453

2012

Volltextzugriff (PDF)

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis

Annals of the American Thoracic Society, 2015-08, Vol.12 (8), p.1170-1176

2015

Volltextzugriff (PDF)

Remembering Alan Lucier

Journal of forestry, 2014-07, Vol.112 (4), p.383-384

2014

Volltextzugriff (PDF)

The short inflammatory bowel disease questionnaire : A quality of life instrument for community physicians managing inflammatory bowel disease

The American journal of gastroenterology, 1996-08, Vol.91 (8), p.1571-1578

1996

Volltextzugriff (PDF)

Portrait de l’artiste en réformiste

Agone : philosophie, critique, & littérature, 2007-09 (37), p.71-96

Glu, Bendy

2007

Volltextzugriff (PDF)

Culture & propagande « Lille 2004 », capitale européenne de la culture

Agone : philosophie, critique, & littérature, 2005-11 (34), p.7-26

Glu, Bendy

2005

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Cystic Fibrosis
(5)
Cystic Fibrosis - Physiopathology
(5)
Humans
(5)
Child
(4)
Female
(4)
Male
(4)
Respiratory System
(4)
Risk Factors
(3)
Adolescent
(2)
Biological And Medical Sciences
(2)
Child, Preschool
(2)
Cystic Fibrosis - Drug Therapy
(2)
Cystic Fibrosis - Genetics
(2)
Cystic Fibrosis - Microbiology
(2)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(2)
Follow-Up Studies
(2)
Forestry
(2)
Infant
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

711 Outcomes of diverse recruitment strategies in the Home-Reported Outcomes with CFTR Modulator Therapy study

319 I1023_V1024del-CFTR theratyping using patient-derived nasal epithelial cells

671 Home reported outcomes in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor: feasibility of conducting a real-world protocol

P092 Preliminary observations of treatment and symptom reporting in the Home-Reported Outcomes in cystic fibrosis study (HERO-2)

P113 Home reported outcomes (HERO-2) in people with cystic fibrosis taking elexacaftor/tezacaftor/ivacaftor: self-reported changes in use of chronic daily therapies at enrollment

140 Home Reported Outcomes Study (HERO-2): end-of-study participant-reported physical and mental health changes

709 Longitudinal Cystic Fibrosis Respiratory Symptom Diary—Chronic Respiratory Infection Symptom Score Questionnaire and PROMIS10 scores from the Home Reported Outcomes Study in people with CF taking elexacaftor/tezacaftor/ivacaftor

141 Lung function and pulmonary exacerbations in individuals who discontinue chronic daily respiratory therapies: results of the Home Reported Outcomes Study-2 (HERO-2)

P105 Patient reported outcomes in people with CF taking elexacaftor/tezacaftor/ivacaftor (ETI) in the Home-Reported Outcomes (HERO-2) study

610 Clinical features associated with changes in chronic daily therapies in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor: Results from the Home Reported Outcomes 2 Study

115 Baseline symptom tracking in the Home Reported Outcome Study (HERO-2) in people with cystic fibrosis taking elexacaftor-tezacaftorivacaftor

Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life

A27 ADVANCES IN PEDIATRIC SLEEP: The Effect Of Continuous Positive Airway Pressure (cpap) Therapy On Obese Children With Stable Asthma

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

A104 ASTHMA EPIDEMIOLOGY: Association Between Sugar Cane Burning And The Prevalence Of Asthma, Atopy And Pulmonary Function Changes In Rural Honduran Children

Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients

Effectiveness of forestry best management practices (BMPs) for reducing the risk of forest herbicide use to aquatic organisms in streams

Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort

Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis

Remembering Alan Lucier

The short inflammatory bowel disease questionnaire : A quality of life instrument for community physicians managing inflammatory bowel disease

Portrait de l’artiste en réformiste

Culture & propagande « Lille 2004 », capitale européenne de la culture

Suchergebnisse filtern